After London and Paris, Rimon Set on Further International Expansion, Law360 Reports
Michael Moradzadeh
Rimon Partner Rodrigo Castillo Cottin Highly Recommended by Leaders League for Wealth Management
Rodrigo Castillo Cottin
Global Law Firm Rimon PC expands international reach with opening of new London office
Roger Parker
We congratulate our client, OneMedNet Corporation, on the announcement of their de-SPAC transaction with Data Knights Acquisition Corp. The transaction will result in a newly combined company named OneMedNet. Upon closing, OneMedNet will continue to be led by its CEO, Mr. Paul Casey, a 40-year public company veteran with a proven track record driving value…
NEW YORK, Jan. 13, 2022 /PRNewswire/ — Broad Capital Acquisition Corp. (NASDAQ: BRACU, the “Company”) announced today that it closed its $100 million initial public offering of 10,000,000 units at $10.00 per unit. Each unit consists of one share of common stock and one right to receive one-tenth of one share of common stock upon the consummation of…
Law360 (November 30, 2021, 3:50 PM EST) — Canna-Global Acquisition Corp., a special purpose acquisition company aiming to create a multinational cannabis operator, began trading Tuesday on the Nasdaq after raising $200 million in an initial public offering, with guidance by Rimon and underwriter’s counsel Schiff Hardin. The blank-check company, which is targeting the cannabis industry and trading…
Kuala Lumpur, Malaysia / November 18, 2021 / Energem Corp. (the “Company”) announced today the closing of its initial public offering of 10,000,000 units at $10.00 per unit. Each unit consists of one Class A ordinary share and one redeemable warrant. Each warrant entitles the holder to purchase one Class A ordinary share at a…
Washington, D.C. – Increasing its team of pharmaceutical and biotech IP attorneys, Rimon is pleased to welcome Dr. Ping Wang, Dr. Michael Ye, and Dr. John Murray as Intellectual Property and Patent Prosecution partners in the firm’s Washington D.C. office. The group joins the firm from Morris Manning and Martin, LLP. “Pharma and biotech are…
Litigation financing is on the rise in the United States and provides some claimants a valuable means for paying the costs of pursuing a legal claim. Lawyer involvement in litigation financing transactions raises many ethical issues for a lawyer such as competence, duty of loyalty, the potential waiver of privilege and interference by a third…
I. Introduction The 2011 America Invents Act (“AIA”) introduced two new proceedings to challenge patent claims in the U.S. Patent & Trademark Office (“USPTO”): “inter partes review” (“IPR”) and “post grant review” (“PGR”).[1] To challenge one or more patent claims in an IPR or PGR proceeding, the challenger must file a petition, which is reviewed…
Unlike the Chinese patent rules or the rules under the European Patent Treaty, both of which require literal or word-by-word support in the specification of a patent application for a claim limitation[1], US patent practice allows, favors, and encourages an applicant to claim more than the examples described in the specification. A common misconception among…
On September 1, Partner Juan Zuniga presented on the topic of legal entities at the Academia de Accessity. The event was attended by a group of 25 aspiring entrepreneurs and was hosted by the Accessity Academy for Business Success and the Eva Longoria Foundation. Academia de Accessity gives Latinas in Southern California the tools they…
